Viewing Study NCT05173805


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-05-17 @ 5:55 PM
Study NCT ID: NCT05173805
Status: UNKNOWN
Last Update Posted: 2023-07-18
First Post: 2021-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None with a KRAS mutation View